Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Dold

Showing results (11-20 of 66) with videos related to

Pageof 7
Sort By:
Psychotherapy and Psychosomatics|September 14, 2017
Dose Escalation of Antidepressants in Unipolar Depression: A Meta-Analysis of Double-Blind, Randomized Controlled TrialsMarkus Dold, Lucie Bartova, Rainer Rupprecht, et al.
The Cochrane Database of Systematic Reviews|July 9, 2014
Trifluoperazine versus low-potency first-generation antipsychotic drugs for schizophreniaMagdolna Tardy, Markus Dold, Rolf R Engel, et al.
The Cochrane Database of Systematic Reviews|September 2, 2014
Flupenthixol versus low-potency first-generation antipsychotic drugs for schizophreniaMagdolna Tardy, Markus Dold, Rolf R Engel, et al.
Schizophrenia Research|May 27, 2015
Dose escalation of antipsychotic drugs in schizophrenia: a meta-analysis of randomized controlled trialsMarkus Dold, Gernot Fugger, Martin Aigner, et al.
Neuropsychiatrie : Klinik, Diagnostik, Therapie Und Rehabilitation : Organ Der Gesellschaft Osterreichischer Nervenarzte Und Psychiater|June 22, 2012
[Effect of the degree of instability during therapy on the treatment outcome of in-patient psychotherapy of obsessive-compulsive disorder]Markus Dold, Ulrike Demal, Gerhard Lenz, et al.
Psychotherapy and Psychosomatics|February 28, 2015
Second-Generation Antipsychotic Drugs in Anorexia Nervosa: A Meta-Analysis of Randomized Controlled TrialsMarkus Dold, Martin Aigner, Megan Klabunde, et al.
The Cochrane Database of Systematic Reviews|May 3, 2014
Carbamazepine for schizophreniaStefan Leucht, Bartosz Helfer, Markus Dold, et al.
The Cochrane Database of Systematic Reviews|January 17, 2015
Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disordersMarkus Dold, Myrto T Samara, Chunbo Li, et al.
The British Journal of Psychiatry : the Journal of Mental Science|February 3, 2012
Putting the efficacy of psychiatric and general medicine medication into perspective: review of meta-analysesStefan Leucht, Sandra Hierl, Werner Kissling, et al.
The Cochrane Database of Systematic Reviews|October 29, 2015
Lithium for schizophreniaStefan Leucht, Bartosz Helfer, Markus Dold, et al.
Pageof 7

Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
Psychotherapy and Psychosomatics|September 14, 2017
Dose Escalation of Antidepressants in Unipolar Depression: A Meta-Analysis of Double-Blind, Randomized Controlled TrialsMarkus Dold, Lucie Bartova, Rainer Rupprecht, et al.
The Cochrane Database of Systematic Reviews|July 9, 2014
Trifluoperazine versus low-potency first-generation antipsychotic drugs for schizophreniaMagdolna Tardy, Markus Dold, Rolf R Engel, et al.
The Cochrane Database of Systematic Reviews|September 2, 2014
Flupenthixol versus low-potency first-generation antipsychotic drugs for schizophreniaMagdolna Tardy, Markus Dold, Rolf R Engel, et al.
Schizophrenia Research|May 27, 2015
Dose escalation of antipsychotic drugs in schizophrenia: a meta-analysis of randomized controlled trialsMarkus Dold, Gernot Fugger, Martin Aigner, et al.
Neuropsychiatrie : Klinik, Diagnostik, Therapie Und Rehabilitation : Organ Der Gesellschaft Osterreichischer Nervenarzte Und Psychiater|June 22, 2012
[Effect of the degree of instability during therapy on the treatment outcome of in-patient psychotherapy of obsessive-compulsive disorder]Markus Dold, Ulrike Demal, Gerhard Lenz, et al.
Psychotherapy and Psychosomatics|February 28, 2015
Second-Generation Antipsychotic Drugs in Anorexia Nervosa: A Meta-Analysis of Randomized Controlled TrialsMarkus Dold, Martin Aigner, Megan Klabunde, et al.
The Cochrane Database of Systematic Reviews|May 3, 2014
Carbamazepine for schizophreniaStefan Leucht, Bartosz Helfer, Markus Dold, et al.
The Cochrane Database of Systematic Reviews|January 17, 2015
Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disordersMarkus Dold, Myrto T Samara, Chunbo Li, et al.
The British Journal of Psychiatry : the Journal of Mental Science|February 3, 2012
Putting the efficacy of psychiatric and general medicine medication into perspective: review of meta-analysesStefan Leucht, Sandra Hierl, Werner Kissling, et al.
The Cochrane Database of Systematic Reviews|October 29, 2015
Lithium for schizophreniaStefan Leucht, Bartosz Helfer, Markus Dold, et al.
Pageof 7